Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC D-+-Galactosamine 1772-03-8 500mg
Supplier: Apexbio Technology LLC B7881500
D-plus-Galactosamine is a small-molecule agent used to induce hepatocellular injury for research applications It functions by disrupting the intracellular metabolism of uridine diphosphate (UDP)-sugars consequently impairing glycoprotein and glycolipid biosynthesis and triggering metabolic disturbances in hepatocytes D-plus-Galactosamine exerts its biological activity primarily through the induction of hepatocellular damage inflammatory responses and apoptotic signaling cascades via UDP-sugar metabolic disruption Based on these pharmacological properties D-plus-Galactosamine holds research potential in modeling acute hepatic injury studying hepatitis pathogenesis and liver dysfunction investigating inflammation-mediated hepatocyte death mechanisms and evaluating hepatoprotective strategies
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?